Aurobindo gets US FDA approval

New Delhi, June 15: Domestic drug maker Aurobindo Pharma Ltd today said the US Food and Drug Administration (FDA) has approved its Cefpodoxime proxetil tablets in the strengths of 100mg and 200mg.

This is the seventh cephalosporin approval for the company, a statement said.

Cefpodoxime is the generic version of Pharmacia Upjohn's Vantin and is mostly used to treat acute otitis media, community acquired Pneumoniae, uncomlicated urinary tract infections and skin infections.

US FDA has also confirmed its approval for Cefpodoxime proxetil for oral suspension in the strengths of 50mg/5ml and 100mg/5ml.

UNI